Fig. 1From: Responses of metastatic basal cell and cutaneous squamous cell carcinomas to anti-PD1 monoclonal antibody REGN2810 a Lung metastases in BCC patient indicated by yellow arrows at baseline (upper, 1.6Â cm; lower 1.4Â cm), left, and at Week 24 (upper, 1.3Â cm; lower, 0.6Â cm), right. b Neck mass in CSCC patient at baseline (3.1Â cm), left, and at Week 16 (1.6Â cm), right. The lesions shown are the only target lesions for both patientsBack to article page